Showing results (61-70 of 1,273) with videos related to
Sort By:
Pageof 128
Clinical Colorectal Cancer|January 26, 2019
Impact of Sex on Chemotherapy Toxicity and Efficacy Among Patients With Metastatic Colorectal Cancer: Pooled Analysis of 5 Randomized TrialsOmar Abdel-RahmanClinical Colorectal Cancer|December 19, 2017
Planned Safety Analysis of the ACTS-CC 02 Trial: A Randomized Phase III Trial of S-1 With Oxaliplatin Versus Tegafur and Uracil With Leucovorin as Adjuvant Chemotherapy for High-Risk Stage III Colon CancerTetsuya Kusumoto, Eiji Sunami, Mitsuyoshi Ota, et al.Clinical Colorectal Cancer|December 17, 2013
A pilot study assessing the incidence and clinical significance of circulating tumor cells in esophagogastric cancersFrancesco Sclafani, Elizabeth Smyth, David Cunningham, et al.Clinical Colorectal Cancer|December 28, 2013
Phase I trial of selective internal radiation therapy for chemorefractory colorectal cancer liver metastases progressing after hepatic arterial pump and systemic chemotherapyConstantinos T Sofocleous, Alessandra R Garcia, Neeta Pandit-Taskar, et al.Clinical Colorectal Cancer|October 1, 2013
A phase 1B study of dulanermin in combination with modified FOLFOX6 plus bevacizumab in patients with metastatic colorectal cancerZev A Wainberg, Wells A Messersmith, Parvin F Peddi, et al.Clinical Colorectal Cancer|December 21, 2013
Correlation of lactate dehydrogenase isoenzyme profile with outcome in patients with advanced colorectal cancer treated with chemotherapy and bevacizumab or cediranib: Retrospective analysis of the HORIZON I studyJair Bar, Stuart Spencer, Shethah Morgan, et al.Clinical Colorectal Cancer|November 6, 2013
Axitinib or bevacizumab plus FOLFIRI or modified FOLFOX-6 after failure of first-line therapy for metastatic colorectal cancer: a randomized phase II studyJohanna C Bendell, Christophe Tournigand, Anna Swieboda-Sadlej, et al.Clinical Colorectal Cancer|March 18, 2021
Multicohort Retrospective Validation of a Predictive Biomarker for Topoisomerase I InhibitorsKoji Ando, Al Ozonoff, Shin-Yin Lee, et al.Clinical Colorectal Cancer|November 20, 2021
Long-term Patterns of Failure and the Value of Blood Prognostic Markers in Anal Cancers Treated With Intensity-Modulated Radiation TherapyJoseph Sia, Wei Mou Lim, Ryan Anthony Agas, et al.Clinical Colorectal Cancer|November 28, 2021
Localized Well-Differentiated Rectal Neuroendocrine Tumors - Where Are We in 2021?Larissa Costa Amorim, Artur Rodrigues Ferreira, Rodrigo Oliva Perez, et al.Pageof 128